XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows From Operating Activities:    
Net loss $ (9,225,220) $ (8,146,909)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 904,604 276,582
Issuance of common stock for services 95,884
Amortization of operating lease right-of-use asset 42,879 39,671
Depreciation 730 153
Changes in operating assets and liabilities:    
Prepaid expenses 217,852 (1,161,066)
Deposits 19,031
Accounts payable 512,108 (872,060)
Accrued expenses 2,514,649 88,442
Accrued compensation 327,690 225,875
Accrued interest 3,968
Operating lease liability (42,698) (38,272)
Net Cash Used In Operating Activities (4,651,522) (9,564,585)
Cash Flows From Financing Activities:    
Proceeds from sale of NoveCite, Inc. common stock 500
Net Cash Provided By Financing Activities 500
Net Change in Cash and Cash Equivalents (4,651,522) (9,564,085)
Cash and Cash Equivalents - Beginning of Period 70,072,946 13,859,748
Cash and Cash Equivalents - End of Period $ 65,421,424 $ 4,295,663